Frederik Giesel
Frederik Giesel co-developed FAPI PET imaging and now leads nuclear medicine in Düsseldorf.
Frederik Giesel co-led the first-in-human FAPI PET studies in Heidelberg and continues to develop FAP-targeted imaging and therapy; he moved to Düsseldorf as director of nuclear medicine.
| Title | Journal | Year |
|---|---|---|
| 68Ga-FAPI PET/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents | Journal of Nuclear Medicine | 2019 |
Pages like this
not linked directly; found by shared links- PersonUwe Haberkorn
Shares A university cyclotron network with shared regulatory files for new tracers, European Association of Nuclear Medicine, Heidelberg University Hospital / NCT / DKFZ, FAPI PET.
- IdeaFAP theranostics as a pan-cancer stromal strategy
Shares A university cyclotron network with shared regulatory files for new tracers, FAPI PET, FAP.
- CompanySOFIE Biosciences
Shares Heidelberg University Hospital / NCT / DKFZ, FAPI PET, FAP.
- PersonClemens Kratochwil
Shares European Association of Nuclear Medicine, Heidelberg University Hospital / NCT / DKFZ.
- ProductFAP-2286 (177Lu / 68Ga)
Shares University Hospital Düsseldorf / CIO Düsseldorf, FAPI PET, FAP.
- TechnologyCAR-T against stroma: fibroblasts and myeloid cells
- PersonShaoli Song
- TermCancer-associated fibroblasts (CAFs)